换一批
换一批摘要INTRODUCTION Currently in China,about 290 million people have cardiovascular disease (CVD).Cardiovascular-relevant morbidity and mortality in Chinese population rose quickly,and increasing number of the patients has brought about a serious health problem to the society.CVD has become the leading cause of death in China,and among the overall mortality,two in every five patients have CVD.Fortunately,Chinese patent medicines play an ever-increasing role in the prophylaxis,treatment,and emergency therapy of CVDs.
更多相关知识
栏目名称
Expert Consensus
DOI
10.4103/0366-6999.204106
发布时间
2017-05-22
- 浏览23
- 被引4
- 下载8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
